16:31 IST
BSE
Share Pledge
Ajanta Pharma Share Pledge
Aayush Agrawal (Trustee of Aayush Agrawal Trust) has released a pledge on 1,736,353 equity shares of Ajanta Pharma Limited. This follows loan repayment.
Ajanta Pharma Ltd
- Share price
- ₹3,547.80
- Market cap
- ₹44,333 Cr
- Revenue (annual)
- ₹5,453 Cr
- Net profit (annual)
- ₹1,056 Cr
- P/E (TTM)
- 39.1×Sector 50.4×
- Promoter holding
- 63.48%-2.77% QoQ
- FII holding
- 7.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
17:38 IST
BSE
Earnings Call
Ajanta Pharma Earnings Call Transcript: Key Takeaways
Ajanta Pharma reports strong Q1 FY27 results, but management remains cautious about sustainability, guiding for normalization in the US and acknowledging geopolitical headwinds in Asia.
- Call
- Guides 18% growth
14:36 IST
BSE
Financial Results
Ajanta Pharma Q1 FY27 Results: Net Profit ₹334.2 Cr, Up 30.9% YoY
Ajanta Pharma Ltd reported revenue from operations of ₹1,626 Cr (+24.8% YoY) and net profit of ₹334.2 Cr (+30.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹334.2 Cr · +30.9% YoY
16:34 IST
BSE
Earnings Call
Ajanta Pharma Earnings Call: Key Takeaways
Ajanta Pharma achieved record FY26 revenue >₹5,000cr and PAT >₹1,000cr, driven by strong US and Africa performance despite Asia supply chain headwinds.
17:58 IST
BSE
Earnings Call
Ajanta Pharma Earnings Call: Key Takeaways
Ajanta Pharma hit major milestones in FY26, surpassing ₹5,000cr revenue and ₹1,000cr PAT, but faces logistics-driven volatility in Asia and rising costs from Middle East conflicts.
15:25 IST
BSE
Financial Results
Ajanta Pharma Q4 FY26 Results: Net Profit ₹266.7 Cr, Up 18.4% YoY
Ajanta Pharma Ltd reported revenue from operations of ₹1,422 Cr (+21.5% YoY) and net profit of ₹266.7 Cr (+18.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹266.7 Cr · +18.4% YoY